{"disease":{"id":"growth-failure","name":"growth failure"},"drugs":{"marketed":[{"drug_id":"lonapegsomatropin","indication_name":"Growth failure due to inadequate secretion of endogenous growth hormone (GH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Skytrofa","generic_name":"LONAPEGSOMATROPIN","company_name":"Ascendis Pharma Encocrinology Div A/S","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"Recombinant Human Growth Hormone [EPC]","quality_score":10,"revenue":"446","mechanism":"Skytrofa works by mimicking the natural growth hormone to stimulate growth in individuals with growth hormone deficiency."},{"drug_id":"lonapegsomatropin-tcgd","indication_name":"Pediatric Growth Failure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"SKYTROFA","generic_name":"LONAPEGSOMATROPIN-TCGD","company_name":"ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S","drug_phase":"marketed","molecular_target":"growth hormone (GH) receptor","drug_class":"Recombinant Human Growth Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":"SKYTROFA binds to the GH receptor, triggering signal transduction and various pharmacodynamic effects, including growth stimulation in pediatric GHD."},{"drug_id":"somapacitan-beco","indication_name":"Growth failure due to inadequate GH secretion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"SOGROYA","generic_name":"SOMAPACITAN-BECO","company_name":"NOVO NORDISK INC","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"somapacitan-beco","indication_name":"Growth failure associated with Noonan syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"SOGROYA","generic_name":"SOMAPACITAN-BECO","company_name":"NOVO NORDISK INC","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"somatrogon","indication_name":"Growth failure due to inadequate secretion of endogenous growth hormone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ngenla","generic_name":"somatrogon","company_name":"Pfizer Ireland Pharmaceuticals","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Ngenla works by binding to the growth hormone receptor, mimicking the action of natural growth hormone."},{"drug_id":"somapacitan","indication_name":"Growth failure associated with Noonan syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sogroya","generic_name":"SOMAPACITAN","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":70,"revenue":null,"mechanism":"Sogroya works by binding to the growth hormone receptor, mimicking the action of growth hormone and stimulating growth and development."},{"drug_id":"chembl-chembl4297830","indication_name":"Growth failure due to inadequate growth hormone secretion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SOMATROGON","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"lonapegsomatropin-tcgd","indication_name":"Growth failure due to inadequate secretion of endogenous growth hormone (GH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"SKYTROFA","generic_name":"LONAPEGSOMATROPIN-TCGD","company_name":"ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S","drug_phase":"marketed","molecular_target":"growth hormone (GH) receptor","drug_class":"Recombinant Human Growth Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":"SKYTROFA binds to the GH receptor, triggering signal transduction and various pharmacodynamic effects, including growth stimulation in pediatric GHD."},{"drug_id":"somapacitan","indication_name":"Growth failure due to inadequate GH secretion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sogroya","generic_name":"SOMAPACITAN","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":70,"revenue":null,"mechanism":"Sogroya works by binding to the growth hormone receptor, mimicking the action of growth hormone and stimulating growth and development."}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03312049","title":"Aflatoxin Birth Cohort Study Nepal (AflaCohort)","phase":"","overall_status":"COMPLETED","enrollment_count":1675,"lead_sponsor_name":"Tufts University","has_results":false},{"nct_id":"NCT03717584","title":"A Cohort Study of the Intestinal Microbiota of Premature Infants","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT05121935","title":"MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":254,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT07082881","title":"Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Suqian First Hospital","has_results":false},{"nct_id":"NCT03891589","title":"Optimized Complementary Feeding With or Without Home Fortification Prevents Decrease of Micronutrient and Growth","phase":"NA","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Udayana University","has_results":false},{"nct_id":"NCT03730883","title":"The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants","phase":"NA","overall_status":"UNKNOWN","enrollment_count":214,"lead_sponsor_name":"Princess Anna Mazowiecka Hospital, Warsaw, Poland","has_results":false},{"nct_id":"NCT03522558","title":"Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT06497907","title":"Environmental Enteropathy Among Infants and Children With Growth Faltering","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04640467","title":"Prediction of Late Fetal Growth Restriction Using Cerebroplacental Ratio","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05393934","title":"Growth Faltering Intervention Using Pediatric Nutritional Care (PNC) vs.PNC& FSMP","phase":"NA","overall_status":"UNKNOWN","enrollment_count":188,"lead_sponsor_name":"Danone Specialized Nutrition Indonesia","has_results":false},{"nct_id":"NCT04325308","title":"Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT03761498","title":"Is There a Microbiome Associated With Poor Growth in Preterm Infants?","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":118,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT03015909","title":"Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"LG Life Sciences","has_results":false},{"nct_id":"NCT04565314","title":"ELICIT 2.0: Pilot Study of the Effect of Maternal Protein Supplementation During Lactation on Childhood Growth","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT04587271","title":"Nutritional Impact of Moringa Oleifera Leaf Supplementation in Mothers and Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Suzanna L Attia","has_results":true},{"nct_id":"NCT04640805","title":"Targeted Fortification of Pasteurized Donor Human Milk","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61,"lead_sponsor_name":"KK Women's and Children's Hospital","has_results":false},{"nct_id":"NCT04809350","title":"Human Milk Fortification With Adjustable Versus Targeted Method","phase":"NA","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT06103513","title":"Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT06652087","title":"Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT03532555","title":"Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia","phase":"NA","overall_status":"TERMINATED","enrollment_count":37,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT03563391","title":"A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Nutricia North America","has_results":false},{"nct_id":"NCT04226586","title":"Nutritional Stimulation of Growth in Children With Short Stature","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Arkansas Children's Hospital Research Institute","has_results":false},{"nct_id":"NCT02412566","title":"SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}